Literature DB >> 11123071

Recent developments in the therapy of spondyloarthropathies.

M Stone1, R D Inman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123071     DOI: 10.1007/s11926-000-0063-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  11 in total

1.  Inhibition of folate enzymes by sulfasalazine.

Authors:  J Selhub; G J Dhar; I H Rosenberg
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

2.  Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis.

Authors:  A Lauhio; M Leirisalo-Repo; J Lähdevirta; P Saikku; H Repo
Journal:  Arthritis Rheum       Date:  1991-01

3.  Tumor necrosis factor receptor p55 controls the severity of arthritis in experimental Yersinia enterocolitica infection.

Authors:  Y X Zhao; H Zhang; B Chiu; U Payne; R D Inman
Journal:  Arthritis Rheum       Date:  1999-08

4.  Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.

Authors:  D O Clegg; D J Reda; M Abdellatif
Journal:  Arthritis Rheum       Date:  1999-11

5.  No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study.

Authors:  J Sieper; C Fendler; S Laitko; H Sörensen; C Gripenberg-Lerche; F Hiepe; R Alten; W Keitel; A Groh; J Uksila; U Eggens; K Granfors; J Braun
Journal:  Arthritis Rheum       Date:  1999-07

Review 6.  Therapy with cyclosporine in psoriatic arthritis.

Authors:  I Olivieri; C Salvarani; F Cantini; L Macchioni; A Padula; L Niccoli; L Boiardi; I Portioli
Journal:  Semin Arthritis Rheum       Date:  1997-08       Impact factor: 5.532

7.  Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis.

Authors:  H Mielants; E M Veys; R Joos
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

8.  Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals.

Authors:  T Höhler; T Schäper; P M Schneider; K H Meyer zum Büschenfelde; E Märker-Hermann
Journal:  Arthritis Rheum       Date:  1998-08

9.  Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis.

Authors:  R F Willkens; H J Williams; J R Ward; M J Egger; J C Reading; P J Clements; E S Cathcart; C O Samuelson; M A Solsky; S B Kaplan
Journal:  Arthritis Rheum       Date:  1984-04

10.  The use of sulfasalazine in psoriatic arthritis: a clinic experience.

Authors:  P Rahman; D D Gladman; R J Cook; Y Zhou; G Young
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.